By Wendy Netter Epstein Earlier this month, CVS announced plans to buy Aetna— one of the nation’s largest health insurers—in a $69 billion deal. Aetna and CVS pitched the deal to the public largely on the promise of controlling costs and improving efficiency in their operations, which they say will inhere to the benefit of…
Health Law Year in P/Review December 12, 2017 8:30 AM – 5:00 PM Wasserstein Hall, Milstein East AB Harvard Law School, 1585 Massachusetts Ave., Cambridge, MA Register for this event The Sixth Annual Health Law Year in P/Review symposium will feature leading experts discussing major developments during 2017 and what to watch out for in 2018. The…
Health Law Year in P/Review December 12, 2017 8:30 AM – 5:00 PM Wasserstein Hall, Milstein East AB Harvard Law School, 1585 Massachusetts Ave., Cambridge, MA Register for this event The Sixth Annual Health Law Year in P/Review symposium will feature leading experts discussing major developments during 2017 and what to watch out for in 2018. The…
Health Law Year in P/Review December 12, 2017 8:30 AM – 5:00 PM Wasserstein Hall, Milstein East AB Harvard Law School, 1585 Massachusetts Ave., Cambridge, MA Register for this event The Sixth Annual Health Law Year in P/Review symposium will feature leading experts discussing major developments during 2017 and what to watch out for in 2018. The…
Health Law Year in P/Review December 12, 2017 8:30 AM – 5:00 PM Wasserstein Hall, Milstein East AB Harvard Law School, 1585 Massachusetts Ave., Cambridge, MA Register for this event The Sixth Annual Health Law Year in P/Review symposium will feature leading experts discussing major developments during 2017 and what to watch out for in 2018. The…
By Christopher Robertson This blog has often covered the problem of outrageous medical bills, and explored whether patients have a responsibility to pay the balance on charges that are not covered by insurance. One common pattern is that the patient agrees to pay “all reasonable charges” when they arrive at the emergency room or other…
The Cost of Medications: Current Realities and the Future of Pharmaceutical Pricing Regulations in the United States October 4, 2017 12:00 PM Wasserstein Hall, Milstein East B (2036) Harvard Law School, 1585 Massachusetts Ave., Cambridge, MA From “Pharma Bro” Martin Shkreli to huge price jumps for the EpiPen to the Hepatitis C treatment that costs…
What’s Next for the ACA?: A Lecture by Larry Levitt October 3, 2017 12:00 PM Wasserstein Hall, Room 1010 Harvard Law School, 1585 Massachusetts Ave., Cambridge, MA Join Larry Levitt for a talk about the future of the Affordable Care Act and health care in America. Larry Levitt is Senior Vice President for Special Initiatives at…
The Cost of Medications: Current Realities and the Future of Pharmaceutical Pricing Regulations in the United States October 4, 2017 12:00 PM Wasserstein Hall, Milstein East B (2036) Harvard Law School From “Pharma Bro” Martin Shkreli to huge price jumps for the EpiPen to the Hepatitis C treatment that costs $1000 per pill, pharmaceutical pricing…
What’s Next for the ACA?: A Lecture by Larry Levitt October 3, 2017 12:00 PM Wasserstein Hall, Room 1010 Harvard Law School, 1585 Massachusetts Ave., Cambridge, MA Join Larry Levitt for a talk about the future of the Affordable Care Act and health care in America. Larry Levitt is Senior Vice President for Special Initiatives at…
